400-920-2911 sales@csnpharm.cn
您的位置 : 首页 / Epigenetics / PARP / Pamiparib
CAS No.: 1446261-44-4
Synonyms: BGB-290
BGB-290 shows potent DNA-trapping activity with IC50 of 13 nM. In the cellular assays, BGB-290 inhibits intracellular PAR formation with an IC50 of 0.24 nM.
生物活性
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|---|---|---|---|---|
NCT03427814 | Advanced or Inoperable Gastric... more >> Cancer Collapse << | Phase 3 | Recruiting | September 1, 2021 | - |
NCT03712930 | Metastatic Castration-Resistan... more >>t Prostate Cancer (mCRPC) With Homologous Recombination Deficiency (HRD) Collapse << | Phase 2 | Not yet recruiting | April 30, 2021 | - |
NCT02660034 | Solid Tumors | Phase 1 | Recruiting | September 2019 | - |
实验方案
技术信息
CAS号 | 1446261-44-4 | 储存条件 |
|
|
分子式 | C16H15FN4O | 运输 | 蓝冰 | |
分子量 | 298.31 | 别名 | BGB-290 |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|
NCT03427814 | Advanced or Inoperable Gastric... more >> Cancer Collapse << | Phase 3 | Recruiting | September 1, 2021 | - |
NCT03712930 | Metastatic Castration-Resistan... more >>t Prostate Cancer (mCRPC) With Homologous Recombination Deficiency (HRD) Collapse << | Phase 2 | Not yet recruiting | April 30, 2021 | - |
NCT02660034 | Solid Tumors | Phase 1 | Recruiting | September 2019 | - |
联系我们
官方电话:400-920-2911
二维码
微信公众号 CSN官网